Area of research
Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Medical Imaging Techniques and Applications, and Peptidase Inhibition and Analysis.
Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives
Development and Preclinical Evaluation of [<sup>211</sup>At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer
Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside
Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation
2-[18F]F-<i>p</i>-Aminobenzoic Acid Specifically Detects Infective Endocarditis in Positron Emission Tomography
Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies
Prognostic Value of Tumor Volume Assessment on PSMA PET After<sup>177</sup>Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0
A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer
Erste klinische Anwendung des PSMA-gerichteten Hybridmoleküls PSMA-914 für die präoperative PET/CT Bildgebung und intraoperative fluoreszenzgeführte Navigation
PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies
Library and post-translational modifications of peptide-based display systems
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules
Theranostika in der Nuklearmedizin